Abstract: Hepatocellular carcinoma (HCC) patients with tumor thrombus extended through the major hepatic veins and inferior vena cava into the right atrium (RA) are rare, and most cases are considered as the advanced stage with a poor prognosis.
INTRODUCTION
H epatocellular carcinoma (HCC) is the fifth common malignancy and the second leading cause of cancer-related mortalities in the world. 1 It is high aggressive so that tumor thrombus formation in the major vasculature such as portal vein or hepatic vein is frequent in advanced stages. 2 In some situation, tumor thrombus can grow from any of 3 main hepatic veins through inferior vena cava (IVC) into the right atrium (RA), which usually has a worse prognosis than that of the patients with tumor thrombus in portal or hepatic vein. [3] [4] [5] We report a case of HCC with a tumor thrombus extending into the RA and a tumor thrombus in the portal vein, which is rare to see. Besides, compared with the published literature (Table 1) , our case is one of the youngest patients with the most advanced HCC that invades both the hepatic inflow and outflow vasculature.
CASE REPORT
A 35-year-old man, who is a hepatitis B virus (HBV) carrier, was diagnosed with primary HCC and was thus admitted to our hospital. He claimed abdominal distension. Physical examination was normal. No family or genetic history was found. He had not accepted any therapy before admission. Preoperative computed tomography (CT) revealed multiple carcinoma in the left and right anterior lobe of the liver, with an accompanying tumor thrombus growing from the left hepatic vein through IVC into the RA. It also showed accompanying tumor thrombus in the left branch of the portal vein ( Figure 1 ). Magnetic resonance images showed similar findings with the tumor thrombus severely occupying the RA. Preoperative biochemical examinations revealed alpha-fetoprotein: 3424.53 ng/ mL, HBV-DNA 7.09 Â 10 3 copies/mL and Child-Pugh A grade. At the time of admission, the patient had no symptoms of right heat failure or pumonary embolization. However, it may inevitably cause sudden death, as once either of these happens. Therefore, we performed surgery for this patient. A median sternotomy was added to a subcostal arch incision. The patient was placed on cardiopulmonary bypass. A blood removal tube was inserted from the right heart auricle to the superior vena cava. A blood sending tube was inserted to the aorta. The other blood removal tube was inserted to the intrahepatic IVC, and the cardiopulmonary bypass was started. An incision was made from the RA and the IVC to the left hepatic venous root site, and the tumor thrombus was extracted. The RA and the IVC were sutured for closure. The cardiopulmonary bypass was stopped, and the blood removal and sending tubes were removed. Further resection of liver tumor was not possible because of insufficient remnant liver volume that coincided with preoperative analysis. Thus, after resection of tumor thrombus in the portal vein and ligation of the left branch of portal vein, microwave ablation was performed for the liver tumor. Histologic examination of tumor thrombus was consistent with HCC ( Figure 2 ).
The postoperative course was uneventful except for pleural effusion and ascites. On the 14th postoperative day the patient was recovered and discharged. Transcatheter arterial chemoembolization (TACE) was performed to control the growth of tumor mass at 7 weeks after surgery, when the patient's situation allowed this therapy. A month later, CT showed that HCC has expanded to the right posterior lobe of the liver with recurrence of tumor thrombus in the portal vein (Figure 3 ). Percutaneous microwave ablation was performed. After this treatment, the patient's liver function never recovered to normal, so only symptomatic treatment was performed. At 6 months after the surgery, the patient died with respiratory and circulatory failure induced by hepatic failure.
DISSCUSSION
HCC patients with tumor thrombus extending through the major hepatic veins and IVC into the RA are rare, which was reported in 0.67% to 4.1% of autopsies, 6, 7 and most cases are considered as the advanced stage with a poor prognosis. In our case, the patient is very young, but the tumor thrombus invaded the left branch of portal vein accompanying another tumor thrombus growing from the heptic veins and ICV to the RA. This was an infrequent occurrence and had a dismal prognosis because it carried an increased risk of systemic metastasis and a threat of impending death because of pulmonary embolism or acute heart failure. 4, 8, 9 Hepatic resection with removal of the tumor thrombus was regarded as the most effective therapy. [10] [11] [12] [13] [14] [15] However, in our case, the patient was an HBV carrier and had severe cirrhotic liver. Preoprerative CT showed multiple carcinoma masses in the left and right anterior lobe of the liver, and the remnant liver volume was not sufficient to tolerate hepatectomy. On the contrary, as the growth of tumor thrombus, heart failure, and pulmonary embolism would be inevitable, it could result in sudden death. Thus, even if the tumor is unresectable, it is necessary to remove the tumor thrombus, which would be beneficial for the patient.
As for the prognosis, we reviewed the published English literature and found that in the 1980s postoperative survival was reported to be 1 to 9 months (mean, 6 months), if only the tumor thrombus was extracted. 16 Recently, with the progress of surgical techniques, more and more successful surgical cases for the simultaneous resection of a main liver tumor and tumor thrombus in the RA have been reported. 17, 18 Miyazawa et al 13 had reported that the postoperative survival period of patients whose main tumor of HCC and tumor thrombus in the right atrium could not be extracted without the use of cardiopulmonary bypass ranged from 18 days to 56 months. The mean survival was 20 months. In a retrospective cohort study, Wang et al 10 showed that in the treatment of HCC extending into the IVC/RA, hepatectomy and thrombectomy group had a median survival of 19 months, TACE group had a median survival of 4.5 months, and symptomatic treatment had a median survival of 5 months. These data indicated that surgery, either removing thrombus combined with hepatectomy or only tumor thrombus extraction, might result in better survival when compared with other nonsurgical therapies. Our case was consistent with the survival of patients treated by only tumor thrombus extraction.
To further improve the prognosis, postoperative multidisciplinary treatment is important, 19 although currently there is no consensus on the modality. The patient in our case was treated by TACE and microwave ablation after the operation to control the growth of the tumor. Being afraid of the side effect, the patient did not accept sorafenib, which was shown to improve the overall survival in patients with advanced HCC. 20 In some cases, radiation therapy 21, 22 and chemotherapy 23, 24 were also reported to be the promising modality for advanced HCC as one of the multimodel treatment.
In conclusion, for patients with extension of HCC into the RA and portal vein, surgery is a useful therapeutic modality, even in case that liver tumor cannot be resected. The subsequent course will be determined by whether growth of the residual tumor can be controlled by successive multidisciplinary treatments. 
